We are live on
!
Find out more
TAM
Trillium Asset Management Portfolio holdings
AUM
$3.01B
1-Year Est. Return
19.96%
This Fund
S&P 500
This Quarter
Est. Return
+18.95%
1 Year Est. Return
+19.96%
3 Year Est. Return
+64.51%
5 Year Est. Return
+84.47%
10 Year Est. Return
+399.24%
AUM
$2.78B
AUM Growth
+$410M
(+17%)
Cap. Flow
+$21.3M
Cap. Flow
% of AUM
0.76%
Top 10 Holdings %
Top 10 Hldgs %
26.03%
Holding
240
New
16
Increased
123
Reduced
83
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Unilever
UL
|
+$34.3M |
| 2 |
TSMC
TSM
|
+$8.33M |
| 3 |
Vanguard ESG US Stock ETF
ESGV
|
+$8.23M |
| 4 |
Wolfspeed
WOLF
|
+$6.38M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$5.56M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UN
Unilever NV New York Registry Shares
UN
|
+$33.8M |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$7.72M |
| 3 |
Air Products & Chemicals
APD
|
+$6.74M |
| 4 |
Booking.com
BKNG
|
+$6.01M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$5.57M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.01% |
| 2 | Financials | 16.33% |
| 3 | Healthcare | 11.85% |
| 4 | Consumer Discretionary | 11.68% |
| 5 | Industrials | 10.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Omnicom Group
OMC
$23.4B
| $257K | 0.01% |
4,122
-3,085
| -43% | -$176K |
|
227
FedEx
FDX
$75.4B
| $220K | 0.01% |
846
| – | – |
|
228
American Express
AXP
$230B
| $217K | 0.01% |
1,791
-2,512
| -58% | -$278K |
|
229
iShares US Healthcare ETF
IYH
$3.71B
| $215K | 0.01% |
+4,365
| New | +$206K |
|
230
Blackrock
BLK
$176B
| $208K | 0.01% |
+288
| New | +$191K |
|
231
Donaldson
DCI
$11.4B
| $206K | 0.01% |
+3,688
| New | +$195K |
|
232
Broadcom
AVGO
$2.04T
| $201K | 0.01% |
+4,580
| New | +$179K |
|
|
FLG
233
Flagstar Bank National Association
FLG
$5.82B
| $122K | ﹤0.01% |
3,854
-657
| -15% | -$18.1K |
|
|
REED
234
DELISTED
Reeds, Inc. Common Stock
REED
| $40K | ﹤0.01% |
1,362
| – | – |
|
235
Atmos Energy
ATO
$28.8B
| – | – |
-3,648
| Closed | -$349K |
|
236
Boston Properties
BXP
$11.1B
| – | – |
-13,175
| Closed | -$1.06M |
|
237
Ligand Pharmaceuticals
LGND
$6.36B
| – | – |
-9,626
| Closed | -$572K |
|
238
Interface
TILE
$2.22B
| – | – |
-13,461
| Closed | -$82K |
|
239
Zoetis
ZTS
$30B
| – | – |
-1,247
| Closed | -$206K |
|
|
UN
240
DELISTED
Unilever NV New York Registry Shares
UN
| – | – |
-559,677
| Closed | -$33.8M |
|
Similar funds
SM
CFM
KIA
BGDI
ROTUOC
CM
PCM
DIG
Trillium Asset Management's Q4 2020 Portfolio in Review
As of Q4 2020, Trillium Asset Management held 240 positions worth $2.78B, up 17% from $2.37B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Trillium Asset Management's Q4 2020 filing shows 16 new, 123 increased, 83 reduced and 6 closed positions. Its largest new stake was Unilever: 505,575 shares worth $34.3M. The largest sale was Unilever NV New York Registry Shares, an estimated $33.8M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Trillium Asset Management's largest Q4 2020 buy was Unilever: 505,575 shares worth $34.3M.
- Trillium Asset Management added most to TSMC in Q4 2020, an estimated $8.33M increase.
- Trillium Asset Management's biggest Q4 2020 reduction was Xilinx Inc, cutting an estimated $7.72M.
- Trillium Asset Management fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $33.8M.
- Trillium Asset Management's ten largest holdings make up 26% of its $2.78B portfolio in Q4 2020.
- Trillium Asset Management opened 16 new positions and closed 6 in Q4 2020.
- Trillium Asset Management's portfolio value rose 17% quarter-over-quarter to $2.78B.
Based on Trillium Asset Management's 13F filing for Q4 2020, filed 12 Feb 2021.